Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Emilia Barcia"'
Autor:
Ana Isabel Olías-Molero, Pedro Botías, Montserrat Cuquerella, Jesús García-Cantalejo, Emilia Barcia, Susana Torrado, Juan José Torrado, José María Alunda
Publikováno v:
Parasites & Vectors, Vol 15, Iss 1, Pp 1-10 (2022)
Abstract Background Visceral leishmaniasis (VL) is the most severe form of all leishmanial infections and is caused by infection with protozoa of Leishmania donovani and Leishmania infantum. This parasitic disease occurs in over 80 countries and its
Externí odkaz:
https://doaj.org/article/8122174c926b40b98a13b208849b3506
Autor:
Ana Isabel Olías-Molero, Pedro Botías, Montserrat Cuquerella, Jesús García-Cantalejo, Emilia Barcia, Susana Torrado, Juan José Torrado, José María Alunda
Publikováno v:
Antibiotics, Vol 12, Iss 2, p 362 (2023)
Visceral leishmaniasis (VL), a vector-borne parasitic disease caused by Leishmania donovani and L. infantum (Kinetoplastida), affects humans and dogs, being fatal unless treated. Miltefosine (MIL) is the only oral medication for VL and is considered
Externí odkaz:
https://doaj.org/article/d5c90e4bd9cf45e3b645a258067713c4
Publikováno v:
Pharmaceutics, Vol 15, Iss 1, p 13 (2022)
Parkinson’s disease (PD) is a devastating neurodegenerative disease characterized by progressive destruction of dopaminergic tissue in the central nervous system (CNS). To date, there is no cure for the disease, with current pharmacological treatme
Externí odkaz:
https://doaj.org/article/b8f3ae5f29b949b08bb8ed9be8ea6264
Autor:
Mario Alonso, Emilia Barcia, Juan-Francisco González, Consuelo Montejo, Luis García-García, Mónica-Carolina Villa-Hermosilla, Sofía Negro, Ana-Isabel Fraguas-Sánchez, Ana Fernández-Carballido
Publikováno v:
Pharmaceutics, Vol 14, Iss 11, p 2348 (2022)
Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder, with its incidence constantly increasing. To date, there is no cure for the disease, with a need for new and effective treatments. Morin hydrate (MH) is a naturally occurrin
Externí odkaz:
https://doaj.org/article/5ebda760940c4ae2ba6ade864ecfa257
Autor:
Monica-Carolina Villa-Hermosilla, Sofia Negro, Emilia Barcia, Carolina Hurtado, Consuelo Montejo, Mario Alonso, Ana Fernandez-Carballido
Publikováno v:
Pharmaceutics, Vol 14, Iss 7, p 1392 (2022)
Inhalation therapy is gaining increasing attention for the delivery of drugs destined to treat respiratory disorders associated with cytokine storms, such as COVID-19. The pathogenesis of COVID-19 includes an inflammatory storm with the release of cy
Externí odkaz:
https://doaj.org/article/2ab7928956aa4ff086cc0b033093561f
Autor:
Damián Córdoba Díaz, Ana Isabel Fraguas Sánchez, Manuel Córdoba Díaz, Juan Aparicio-Blanco, Ana Fernandez-Carballido, Sofía Negro Álvarez, Emilia Barcia Hernández, Gonzalo D. García De Fernando Minguillón, Ana Isabel Torres Suárez, Cristina Martín Sabroso
Publikováno v:
Revista Iberoamericana de Tecnología en Educación y Educación en Tecnología, Iss 28 (2021)
Para llevar a cabo la virtualización, es importante adaptar la metodología a seguir, al objetivo, necesidades y contenido de la asignatura. Esto supone un reto a la hora de virtualizar prácticas de laboratorio en materias tecnológicas. Por ello s
Externí odkaz:
https://doaj.org/article/cddb0486391b43e4964f91356f24ba3e
Autor:
Yaquelyn Casanova, Sofía Negro, Karla Slowing, Luis García-García, Ana Fernández-Carballido, Mahdieh Rahmani, Emilia Barcia
Publikováno v:
Pharmaceutics, Vol 14, Iss 5, p 1080 (2022)
To date there is no cure for Parkinson’s disease (PD), a devastating neurodegenerative disorder with levodopa being the cornerstone of its treatment. In early PD, levodopa provides a smooth clinical response, but after long-term therapy many patien
Externí odkaz:
https://doaj.org/article/d8ae4ccce34b42eaac719914e08fe282
Autor:
Monica-Carolina Villa-Hermosilla, Ana Fernández-Carballido, Carolina Hurtado, Emilia Barcia, Consuelo Montejo, Mario Alonso, Sofia Negro
Publikováno v:
Pharmaceutics, Vol 13, Iss 7, p 951 (2021)
Rheumatoid arthritis (RA) is a chronic inflammatory disease with sulfasalazine (SSZ) extensively used for long-term treatment of both juvenile and adult RA. Its use is associated with adverse effects and toxicity due to its non-selective biodistribut
Externí odkaz:
https://doaj.org/article/25bb9002b76d45ca9a5c17ae5899b508
Autor:
Emilia Barcia, Liudmila Boeva, Luis García-García, Karla Slowing, Ana Fernández-Carballido, Yaquelyn Casanova, Sofía Negro
Publikováno v:
Drug Delivery, Vol 24, Iss 1, Pp 1112-1123 (2017)
A new drug delivery system is developed for ropinirole (RP) for the treatment of Parkinson’s disease (PD) consisting of biodegradable poly (D,L-lactide-co-glycolide) (PLGA) nanoparticles (NPs). The formulation selected was prepared with 8 mg RP and
Externí odkaz:
https://doaj.org/article/b7d65e48a86143449b9ce4899ac500a5
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 46(6)
To resume the available literature about digoxin population pharmacokinetic studies in elderly patients. To identify the pathophysiological changes in this subpopulation with clinical implications on digoxin pharmacokinetics.A systematic review was p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::be537e2aa36be2815617cb716686301b
https://pubmed.ncbi.nlm.nih.gov/36520576
https://pubmed.ncbi.nlm.nih.gov/36520576